Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he is taking to improve the assessment of medicines for rarer cancers with small patient populations.
NHS England has advised that it intends to jointly consult with the National Institute for Health and Care Excellence on proposals for a new Cancer Drugs Fund operating model. This will include the future arrangements for the evaluation of cancer drugs, including drugs for rarer cancers with small patient populations. Members of the public and any interested parties will have the opportunity to consider and comment on these proposals.